Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
231.50
+4.00 (+1.76%)
Official Closing Price
Updated: 7:00 PM EST, Feb 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about AbbVie
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
93
94
Next >
3 Stocks to Buy and Hold Forever
↗
September 06, 2025
These stocks are built for the long run.
Via
The Motley Fool
Topics
Intellectual Property
Could These 3 Dividend Kings Be Worth $1 Trillion in 10 Years?
↗
September 04, 2025
There is more to like than the dividend with these companies.
Via
The Motley Fool
Topics
Intellectual Property
Here's How Much You Would Have Made Owning AbbVie Stock In The Last 5 Years
↗
September 03, 2025
Via
Benzinga
1 Safe-and-Steady Stock with Promising Prospects and 2 Facing Headwinds
September 03, 2025
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.
Via
StockStory
Is Healthcare Setting Up to Be a Quiet Leader Into Year-End?
↗
September 02, 2025
Over $11 billion flowed into the popular healthcare sector ETF XLV in Q2 alone, suggesting smart money is positioning for a potential rebound.
Via
MarketBeat
Topics
ETFs
This Is What Whales Are Betting On AbbVie
↗
August 25, 2025
Via
Benzinga
AbbVie Seeks To Expand Psychiatry Pipeline By Acquiring Gilgamesh’s Lead Candidate For Up To $1.2B
↗
August 25, 2025
Via
Stocktwits
5 High-Yield Dividend Stocks I Plan on Holding for the Next 10 Years or Longer
↗
August 31, 2025
Selling these dividend stocks isn't on my radar at all.
Via
The Motley Fool
Topics
Energy
Intellectual Property
The Smartest Dividend Stocks to Buy With $500 Right Now
↗
August 30, 2025
You won't need a lot of money up front to begin raking in dividends from these great stocks.
Via
The Motley Fool
Topics
World Trade
Deal Dispatch: PepsiCo, Sycamore, Dr. Phil, SSENSE, Bain's Chindata Lead M&A, Bankruptcy Moves
↗
August 29, 2025
Deal activity this week included PepsiCo, Sycamore and Bain while the bankruptcy front included SSENSE and Dr. Phil.
Via
Benzinga
Topics
Bankruptcy
2 Reasons to Watch ABBV and 1 to Stay Cautious
August 29, 2025
AbbVie currently trades at $207.60 per share and has shown little upside over the past six months, posting a small loss of 0.7%. The stock also fell short of the S&P 500’s 9.2% gain during that...
Via
StockStory
Topics
Stocks
Supply Chain
AbbVie’s Investigational Drug For Alopecia Yields Positive Outcomes In Late-Stage Study
↗
August 21, 2025
Via
Stocktwits
As the Market Rotates, This Healthcare ETF Is Leading the Way
↗
August 26, 2025
Health care saw some of the worst losses this year. But as the calendar turned to August, it's been leading the market higher. This ETF provides exposure.
Via
MarketBeat
Topics
ETFs
AbbVie Strikes $1.2 Billion Agreement For Next-Gen Psychedelic Depression Treatment
↗
August 26, 2025
Via
Benzinga
3 Top Stocks to Build Your Portfolio Around
↗
August 24, 2025
These great businesses can help patient investors beat the market.
Via
The Motley Fool
3 Unstoppable Dividend Stocks to Buy Right Now
↗
August 23, 2025
Investors will get great dividends and more with these stocks.
Via
The Motley Fool
Topics
World Trade
Tesla's Quality Score Tumbles, While Taiwan Semiconductor's Growth Rating Soars
↗
August 22, 2025
Daily stock price moves often dominate headlines, but shifts in fundamental ranking scores can reveal a deeper story. This week, Benzinga's proprietary Growth data highlighted major swings among...
Via
Benzinga
Want Decades of Passive Income? Buy This Index Fund and Hold It Forever.
↗
August 22, 2025
Sit back and let the income roll in with this great exchange-traded fund.
Via
The Motley Fool
Topics
ETFs
Regulatory Compliance
Stocks
1 Profitable Stock Worth Investigating and 2 That Underwhelm
August 22, 2025
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
Via
StockStory
Jackson Hole Symposium 2025: The Fed Signals a Pivotal Shift Towards Easing
August 21, 2025
The annual Jackson Hole Economic Policy Symposium, a highly anticipated gathering of global central bankers, finance ministers, and leading economists, is currently underway in Wyoming. This year's...
Via
MarketMinute
Topics
Bonds
Credit Cards
Economy
All Eyes on Jackson Hole: Will Jerome Powell Signal Imminent Rate Cuts?
August 21, 2025
Global financial markets are on tenterhooks, fixated on the highly anticipated speech by Federal Reserve Chair Jerome Powell at the annual Jackson Hole Economic Symposium. Investors are keenly awaiting...
Via
MarketMinute
Topics
Bonds
Credit Cards
Economy
A Congress Member Bought Up To $1.17M In AbbVie Stock: Here's What You Need To Know
↗
August 21, 2025
Via
Benzinga
AbbVie's Patch Baldness Study Finds High Hair Coverage Rates With Investigational Drug Upadacitinib
↗
August 21, 2025
AbbVie's Rinvoq Phase 3 trial showed strong efficacy in severe alopecia areata, with many patients achieving significant scalp hair regrowth by week 24.
Via
Benzinga
2 High-Yield Dividend Stocks to Buy in August and Hold for a Decade or Longer
↗
August 21, 2025
These high-yield dividend stocks are built to last.
Via
The Motley Fool
Topics
Intellectual Property
Q2 Earnings Highlights: AbbVie (NYSE:ABBV) Vs The Rest Of The Therapeutics Stocks
August 19, 2025
Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at AbbVie (NYSE:ABBV) and its peers.
Via
StockStory
Topics
Artificial Intelligence
Jackson Hole Symposium Looms: Why Investors Are Holding Their Breath for Powell's Remarks
August 19, 2025
The financial world is abuzz with anticipation as the annual Jackson Hole Economic Symposium draws near, an exclusive gathering hosted by the Federal Reserve Bank of Kansas City in the serene mountains...
Via
MarketMinute
Topics
Bonds
Climate Change
Economy
Federal Reserve Poised for September Rate Cut Amidst High Market Expectations and Powell's Jackson Hole Address
August 19, 2025
Investor sentiment is overwhelmingly pointing towards a significant shift in the Federal Reserve's monetary policy, with a near-certainty of a 25-basis-point interest rate cut anticipated at its...
Via
MarketMinute
Topics
Bonds
Credit Cards
Economy
If You'd Invested $1,000 in AbbVie Stock 10 Years Ago, Here's How Much You'd Have Today
↗
August 18, 2025
You'd be sitting pretty right now.
Via
The Motley Fool
Topics
Intellectual Property
Marjorie Taylor Greene Keeps Buying UnitedHealth Stock Along With Fellow Investors Buffett And Burry
↗
August 15, 2025
Marjorie Taylor Greene may have another winning stock trade with a new filing showing a purchase of UnitedHealth stock.
Via
Benzinga
Here's How Much $100 Invested In AbbVie 5 Years Ago Would Be Worth Today
↗
August 15, 2025
Via
Benzinga
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
93
94
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today